Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

Chief Accounting Officer

See Remarks

General Counsel

Chief Executive Officer

Allovir, Inc., a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific T cell (VST) therapies to prevent and treat devastating viral-associated diseases. The company's lead product is posoleucel, an allogeneic, off-the-shelf VST therapy, to treat BK virus, cytomegalovirus, adenovirus, Epstein-Barr virus, human herpesvirus 6, and JC virus. Its preclinical and clinical development product candidates include ALVR106 for the respiratory syncytial virus, influenza, parainfluenza virus, and human metapneumovirus; ALVR109 to treat SARS-CoV-2 and COVID-19; ALVR107 for treating hepatitis B; and ALVR108. The company was formerly known as ViraCyte, Inc. and changed its name to Allovir, Inc. in May 2019. Allovir, Inc. was incorporated in 2013 and is based in Waltham, Massachusetts.

Allovir, Inc., a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus spe...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-04-22	Premium	sold	Premium	Premium	Premium	Chief Accounting Officer
2024-04-22	Premium	sold	Premium	Premium	Premium	See Remarks
2024-04-22	Premium	sold	Premium	Premium	Premium	General Counsel
2024-04-19	Premium	sold	Premium	Premium	Premium	Chief Executive Officer
2024-04-19	Premium	sold	Premium	Premium	Premium	See Remarks
2024-04-19	Premium	sold	Premium	Premium	Premium	Chief Accounting Officer
2024-04-19	Premium	sold	Premium	Premium	Premium	General Counsel
2024-04-02	Premium	sold	Premium	Premium	Premium	Chief Executive Officer
2024-04-02	Premium	sold	Premium	Premium	Premium	See Remarks
2024-04-02	Premium	sold	Premium	Premium	Premium	General Counsel
2024-04-02	Premium	sold	Premium	Premium	Premium	Chief Accounting Officer
2024-02-21	Premium	sold	Premium	Premium	Premium	Chief Executive Officer
2024-02-20	Premium	sold	Premium	Premium	Premium	See Remarks
2024-02-20	Premium	sold	Premium	Premium	Premium	General Counsel
2024-02-20	Premium	sold	Premium	Premium	Premium	Chief Executive Officer
2024-02-20	Premium	sold	Premium	Premium	Premium	Chief Accounting Officer
2024-02-08	Premium	sold	Premium	Premium	Premium	Chief Accounting Officer
2024-02-05	Premium	sold	Premium	Premium	Premium	See Remarks
2024-02-05	Premium	sold	Premium	Premium	Premium	General Counsel
2024-02-05	Premium	sold	Premium	Premium	Premium	Chief Accounting Officer
2024-02-05	Premium	sold	Premium	Premium	Premium	Chief Executive Officer
2024-01-23	Premium	sold	Premium	Premium	Premium	Chief Accounting Officer
2024-01-23	Premium	sold	Premium	Premium	Premium	General Counsel
2024-01-23	Premium	sold	Premium	Premium	Premium	Chief Executive Officer
2024-01-23	Premium	sold	Premium	Premium	Premium	See Remarks

ALVR - AlloVir, Inc. Stock Price, Fair Value and News

Latest Insider Trading transactions for ALVR